Does Resmed Inc. (NYSE:RMD) have deteriorating prospects?

Resmed Inc. (NYSE:RMD) shares traded 0.06% higher at $152.61 on Wall Street last session. In accordance with the data, 23 analysts cover Resmed Inc. (NYSE:RMD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $267.18 and a low of $158.00, we find […]